[Activity Report] Submission of recommendations to Public Comment on the “Interim Report of the Global Health Strategy in Japan Toward the 2030 Sustainable Development Goals (SDGs)” (February 25, 2022)
date : 3/17/2022
Tags: AMR
On February 25, 2022, Health and Global Policy Institute submitted its opinions to a Public Comment on the “Interim Report of the Global Health Strategy in Japan Toward the 2030 Sustainable Development Goals (SDGs)”
A summary of the submitted opinion is as follows:
While we applaud the inclusion of AMR countermeasures within the interim report, we hope that the final report will go further to recognize AMR countermeasures as a key component of human security and Japan’s commitment to seeing “no one left behind.”
Please see the PDF file found here for further details (information available only in Japanese).
Top Research & Recommendations Posts
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Future of the Healthcare System Project “Policy roadmaps for acting early on NCDs” (March, 2026)
- [Research Report] AMR Policy Update #2: WHO’s First Report on Fungal Infection—Bridging the Gap Between Clinical Practice and R&D



